| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 22, 98-101, Copyright © 1976 by American Association for Clinical Chemistry
BW Steele, DF Koehler, MM Azar, TP Blaszkowski, K Kuba and ME Dempsey
An enzymatic method for cholesterol in serum [Clin. Chem. 20, 470 (1974)] was initially found to be unsatisfactory for measuring cholesterol in high-density-lipoprotein fractions prepared by precipitation with Mn2+. A fine precipitate formed in the cuvette and cholesterol values were falsely increased. We describe a simple, convenient method for circumventing these problems. An ethylenediaminetetraacetate solution is used to reconstitute the enzymatic reagent. Cholesterol values by this procedure correlated with those obtained by the Lipid Research Clinic's procedure for the same lipoprotein fraction preparations (regression slope, .998; Y-intercept, 8.9 mg/liter; correlation coefficient, .984; standard error of the estimate, 16.8 mg/liter). Precision of the assay, including the precipitation step, was calculated. The SDwithin day was 9.7 mg/liter and SDoverall was 23.7 mg/liter. Results for total cholesterol with the modified reagent were linearly related to concentrations exceeding 4 g/liter, thereby permitting determination of high-density-lipoproteins and total cholesterol in a single run.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  R. Rej Clinical Chemistry through Clinical Chemistry: A Journal Timeline Clin. Chem., December 1, 2004; 50(12): 2415 - 2458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. R Hiatt, E. Klepack, M. Nehler, J. G Regensteiner, J. Blue, J. Imus, and M. H Criqui The effect of inhibition of acyl coenzyme A-cholesterol acyltransferase (ACAT) on exercise performance in patients with peripheral arterial disease Vascular Medicine, November 1, 2004; 9(4): 271 - 277. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Schrott, A. G. Fereshetian, R. H. Knopp, H. Bays, P. H. Jones, T. W. Littlejohn, R. McLain, and D. M. Black A Multicenter, Placebo-Controlled, Dose-Ranging Study of Atorvastatin Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(2): 119 - 123. [Abstract] [PDF]
|
|
|
|
 |
|
 S. N. Pimstone, S. E. Gagne, C. Gagne, P. J. Lupien, D. Gaudet, R. R. Williams, M. Kotze, P. W. A. Reymer, J. C. Defesche, J. J. P. Kastelein, et al. Mutations in the Gene for Lipoprotein Lipase : A Cause for Low HDL Cholesterol Levels in Individuals Heterozygous for Familial Hypercholesterolemia Arterioscler Thromb Vasc Biol, October 1, 1995; 15(10): 1704 - 1712. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Diekman, P. J. Lansberg, J. J. P. Kastelein, and W. M. Wiersinga Prevalence and Correction of Hypothyroidism in a Large Cohort of Patients Referred for Dyslipidemia Arch Intern Med, July 24, 1995; 155(14): 1490 - 1495. [Abstract] [PDF]
|
|
|
|
|
|
J. W. Nawrocki, S. R. Weiss, M. H. Davidson, D. L. Sprecher, S. L. Schwartz, P.-J. Lupien, P. H. Jones, H. E. Haber, and D. M. Black Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase Inhibitor Arterioscler Thromb Vasc Biol, May 1, 1995; 15(5): 678 - 682. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. M. Forte, O. Genzel-Boroviczeny, M. A. Austin, L. C. Kao, C. Scott, J. J. Albers, and A. E. D'Harlingue Effect of Total Parenteral Nutrition with Intravenous Fat on Lipids and High Density Lipoprotein Heterogeneity in Neonates JPEN J Parenter Enteral Nutr, September 1, 1989; 13(5): 490 - 500. [Abstract] [PDF]
|
|
|
|
|
|
M. M. Meguid, M. Kurzer, R. J. Hayashi, and M. P. Akahoshi Short-Term Effects of Fat Emulsion on Serum Lipids in Postoperative Patients JPEN J Parenter Enteral Nutr, January 1, 1989; 13(1): 77 - 80. [Abstract] [PDF]
|
|
|
|
|
|
M. H. Luria Effect of Low-Dose Niacin on High-Density Lipoprotein Cholesterol and Total Cholesterol/High-Density Lipoprotein Cholesterol Ratio Arch Intern Med, November 1, 1988; 148(11): 2493 - 2495. [Abstract] [PDF]
|
|
|
|
|
|
I. Lipinska and V. Gurewich The Value of Measuring Percent High-Density Lipoprotein in Assessing Risk of Cardiovascular Disease Arch Intern Med, March 1, 1982; 142(3): 469 - 472. [Abstract] [PDF]
|
|
|
|
 |
|
 A. R. Nubiola, L. Masana, S. Masdeu, and J. Rubies-Prat High-Density Lipoprotein Cholesterol in Cerebrovascular Disease Arch Neurol, July 1, 1981; 38(7): 468 - 468. [Abstract] [PDF]
|
|
|
|
 |
|
 A. I. Goldman, B. W. Steele, H. W. Schnaper, A. E. Fitz, E. D. Frohlich, and H. M. Perry Jr Serum Lipoprotein Levels During Chlorthalidone Therapy: A Veterans Administration-National Heart, Lung, and Blood Institute Cooperative Study on Antihypertensive Therapy: Mild Hypertension JAMA, October 10, 1980; 244(15): 1691 - 1695. [Abstract] [PDF]
|
|
|
|
|
|
A. Zampogna, M. H. Luria, S. J. Manubens, and M. A. Luria Relationship Between Lipids and Occlusive Coronary Artery Disease Arch Intern Med, August 1, 1980; 140(8): 1067 - 1069. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
